Mumbai, 28 June 2024: Around 36 per cent of the pharmaceutical manufacturing units inspected by the Indian drug regulator in recent times were forced to shut down due to non-compliance with quality standards, a senior government official said here.

The Central Drug ......
View Details

Related News

• Zydus and Dr. Reddy’s announce licensing agreement for co-marketing of Pertuzumab biosimilar (30-06-2024)

---

• FDA starts probe into ‘foreign particle’ in saline bottle (30-06-2024)

---

• 80% of public health facilities are substandard: Govt survey (29-06-2024)

---

• FSSAI to release tighter regulations for Protein Supplements (29-06-2024)

---

• Kerala govt issues warning on infectious diseases (29-06-2024)

---

• Most kids and teens with conjunctivitis prescribed unnecessary antibiotics despite guidelines: Study (29-06-2024)

---

• Urgent need to strengthen quality management system, documentation & validation processes: DCGI (29-06-2024)

---

• India to make Ozempic-like drugs for diabetes, obesity under PLI by 2026 (29-06-2024)

---

• Orchid Pharma partners with Cipla to launch antibiotic Cefepime-Enmetazobactam in India (28-06-2024)

---

• DCA Telangana seizes spurious 'Vertin Tabs', overpriced 'Itragril-200 Caps' and 3 drugs for misleading claims (28-06-2024)

---